NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









GlyTherix Ltd

GlyTherix Ltd

Private
SydneyHealthcare & Life Scienceshttps://glytherix.com/

Last Round

Series B

Feb 16, 2024

Total Funding Raised

$2.14M

Company Overview

GlyTherix Ltd is a biotechnology company that develops a targeted radiotherapy platform designed to treat solid tumors by delivering antibody radiopharmaceuticals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical Imaging, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

theranosticstargeted radiotherapyradioligand therapyantibody therapeuticsradiopharmaceuticalsGPC-1 targetsolid tumor therapyMiltuximabsee and treatlutetium-177zirconium-89cancer imagingPET imagingprostate cancer treatmentpancreatic cancer treatmentclinical-stage biotechantibody drug conjugatesADC

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GlyTherix Ltd Comparables

Compare GlyTherix Ltd with similar companies based on industry and business-model similarity.

GlyTherix Ltd comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

GlyTherix Ltd Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 16, 2024
Series AJul 22, 2023
GrantSep 8, 2022
GrantDec 1, 2021
GrantMar 3, 2021
Grant
Jul 16, 2020

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2026

    Monthly visitors increased 118% MoM, reaching 2K.

  • May 2, 2025

    Monthly visitors increased 82% MoM, reaching 2K.

GlyTherix Ltd Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GlyTherix Ltd Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GlyTherix Ltd's valuation, stock price, and market status.

Firmographic Details

HeadquartersSydney
Employee Range8
Year Founded2017
Last FundingFeb 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.